Daejung Chemicals & Metals Co., Ltd

Daejung Chemicals & Metals Co., Ltd

KKRX:120240
14,140.00
KRW
-210.00
(-1.46%)
2,023.41EPS
6.78P/E
98.34BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9,955.42
10,454.86
9,727.36
10,076.44
10,977.6
11,040.72
11,216.66
11,300.28
12,394.18
13,469.44
13,007.18
12,871.52
15,068.58
15,882.07
Basic EPS, GAAP
1,691
1,125
1,286
1,244
1,210
1,501
855
1,256
1,177
1,916
1,807
1,350
1,889
2,023.41
Free Cash Flow per Basic Share
738.75
556.51
1,928.4
1,210.47
1,035.3
836.37
-1,033.99
370.05
274.78
1,082.3
1,872.55
1,677.33
1,182.9
1,678.26
Dividend per Share
273.6
249.94
243.36
250.03
249.65
250.42
300.14
300.17
297.62
300.03
400.09
450.12
420.03
- -
Book Value per Share
11,364.95
12,273.52
13,215.62
14,238.6
15,836.68
16,125.27
17,077.66
17,977.79
18,828.87
20,441.96
23,228.35
24,124.34
25,600.37
25,633.31
Tangible Book Value per Share
11,258.67
12,114.49
13,073.62
14,104.48
15,710.07
16,015.58
16,967.95
17,868.49
18,717.46
20,326.22
23,109.57
23,934.9
25,428.95
25,466.67
Basic Weighted Avg Shares
6
6
6
6
6
7
7
7
7
7
7
7
7
7
Sales/Revenue/Turnover
57,679
60,580
57,889
60,943
66,494
73,830
79,607
80,192
88,929
96,608
93,283
92,304
108,081
113,925
Operating Margin (%)
10.42
11.51
14.04
13.82
13.56
12.52
13.02
12.63
8.88
12
11.79
9.19
10.35
11.61
Depreciation Expense
1,283
1,116
1,071
836
727
530
688
1,359
1,651
2,159
2,715
3,436
3,558
3,584
Net Income, GAAP
9,797
6,519
7,653
7,524
7,329
10,037
6,068
8,913
8,445
13,742
12,959
9,681
13,549
14,514
Effective Tax Rate (%)
19.53
17.9
18.27
28.9
17.89
19.37
16.9
18.14
18.39
18.14
4.37
18.39
18.22
22.46
Profit Margin (%)
16.99
10.76
13.22
12.35
11.02
13.6
7.62
11.11
9.5
14.22
13.89
10.49
12.54
12.74
Working Capital
46,077
26,186
34,456
34,971
36,976
47,179
45,914
44,061
47,391
51,223
66,767
66,109
87,981
92,517
LT Debt
10,891
- -
200
200
- -
510
12,410
3,073
477
403
328
242
164
144
Total Equity
65,837
71,101
79,938
86,125
98,221
114,496
121,258
127,969
135,063
146,634
166,621
173,048
183,636
183,873
Return on Invested Capital (%)
7.08
7.09
8.09
7.11
7.94
6.95
6.88
5.88
4.41
6.27
6.3
3.85
4.88
5.47
Return on Capital (%)
14.65
8.8
9.92
9.05
7.94
9.41
4.91
6.52
5.9
9.24
7.97
5.53
7.37
7.87
Return on Common Equity (%)
16.08
9.52
10.13
9.06
7.95
9.44
5.15
7.15
6.42
9.76
8.27
5.7
7.6
8.14

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
9,028
7,028
7,028
LT Borrowings
- -
- -
- -
LT Finance Leases
183
164
144
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
89,665
95,260
98,344

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
106,549
108,609
119,704
Cash, Cash Equivalents & STI
73,082
75,723
83,521
Accounts Receivable, Net
17,683
17,486
19,047
Inventories
14,332
14,278
15,575
Total Current Liabilities
24,487
20,628
27,187
Payables & Accruals
- -
- -
- -
ST Debt
9,028
7,028
7,028
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.75%
7.54%
6.12%
Free Cash Flow
-12.64%
60.38%
-29.46%
Net Income, GAAP
10.65%
13.29%
39.95%
Sales/Revenue/Turnover
6.61%
6.43%
17.09%
Total Cash Common Dividend
- -
8.04%
-6.67%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
22,580
23,343
22,028
24,354
92,304
2025
23,643
26,968
29,087
28,382
108,081
2026
29,487
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
425
358
391
175.91
1,350
2025
371
319.7
451.53
746.52
1,889
2026
505.66
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
450.12
2025
- -
- -
- -
- -
420.03
2026
- -
- -
- -
- -
- -

Company Description

CEO
Young-Joon Song
Full Time Employees
201
Sector
Process industries
Industry
Chemicals: major diversified
Address
Siheung-si South Korea
IPO Date
Dec 20, 2010
Business
Daejung Chemicals & Metals Co., Ltd. is a South Korea-based specialty chemical company primarily engaged in the development, manufacturing, purification, and distribution of high-purity laboratory reagents, raw pharmaceutical materials, and electronic-grade specialty chemicals. Founded in 1968 and headquartered in Siheung-si, Gyeonggi-do, South Korea, the company operates advanced manufacturing and research facilities and serves academic institutions, government research centers, pharmaceutical enterprises, healthcare diagnostics laboratories, and semiconductor manufacturers across domestic and international markets. The company's core product and service portfolio is systematically categorized into: high-purity laboratory reagents, including analytical grade chemicals, high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) solvents, pesticide residue analysis solvents, biological buffers, standard volumetric solutions, and diagnostic reagent formulations; raw pharmaceutical materials and health functional chemicals, encompassing Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, pharmacopeial-grade excipients complying with KP, USP, and EP compendia, and food-grade chemical additives; electronic and industrial process chemicals, consisting of ultra-high purity etching agents, photoresist strippers, precision cleaning solvents, and surface treatment formulations for semiconductor, flat panel display, and printed circuit board (PCB) manufacturing; secondary battery and advanced materials, comprising high-purity chemical precursors and functional additives for energy storage and lithium-ion battery processing; and custom chemical services, offering contract synthesis, toll manufacturing, custom chemical blending, precision purification, and private-label packaging solutions. In recent operations, Daejung Chemicals & Metals Co., Ltd. has accelerated strategic initiatives to expand its footprint in high-value electronic materials and bio-health sectors. The company has upgraded and expanded its cGMP-compliant manufacturing facilities to increase output capacity for pharmaceutical-grade raw materials and custom-synthesized active ingredients. Concurrently, the company has enhanced its product offerings for next-generation semiconductor fabrication and secondary battery material processing by deploying high-efficiency fractional distillation systems and advanced micro-contamination control technologies. Daejung Chemicals & Metals Co., Ltd. has also broadened its international distribution partnerships across the Asia-Pacific region, Europe, and the Americas, while modernizing facility automation and adopting environmentally conscious chemical synthesis processes to improve operational sustainability and fulfill global regulatory requirements.